SOX2 expression diminishes with ageing in several tissues in mice and humans

Mech Ageing Dev. 2019 Jan:177:30-36. doi: 10.1016/j.mad.2018.03.008. Epub 2018 Mar 21.

Abstract

SOX2 (Sex-determining region Y box 2) is a transcription factor expressed in several foetal and adult tissues and its deregulated activity has been linked to chronic diseases associated with ageing. Nevertheless, the level of SOX2 expression in aged individuals at the tissue level has not previously been examined. In this work, we show that SOX2 expression decreases significantly in the brain with ageing, in both humans and rodents. The administration of resveratrol for 6 months in mice partly attenuated this reduction. We also identified an age-related decline in SOX2 mRNA and protein expression in several other organs, namely, the lung, heart, kidney, spleen and liver. Moreover, peripheral blood mononuclear cells (PBMCs) from elderly expressed lower levels of SOX2 than those from young individuals. Mechanistically, SOX2 expression inversely correlates with p16Ink4a levels. Together, these data show a widespread decrease in SOX2 with age, suggesting that the decline in SOX2 expression might be used as a biomarker of ageing.

Keywords: Ageing; Biomarker; SOX2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged, 80 and over
  • Aging / metabolism*
  • Animals
  • Cyclin-Dependent Kinase Inhibitor p16 / metabolism
  • Female
  • Gene Expression Regulation, Enzymologic*
  • Humans
  • Leukocytes, Mononuclear / enzymology
  • Male
  • Mice
  • Middle Aged
  • Organ Specificity
  • SOXB1 Transcription Factors / biosynthesis*

Substances

  • Cyclin-Dependent Kinase Inhibitor p16
  • SOX2 protein, human
  • SOXB1 Transcription Factors
  • Sox2 protein, mouse